Chen ZS - Search Results

1

M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells.

Wu ZX, Peng Z, Yang Y, Wang JQ, Teng QX, Lei ZN, Fu YG, Patel K, Liu L, Lin L, Zou C, Chen ZS. Wu ZX, et al. Among authors: chen zs. Front Oncol. 2020 May 12;10:674. doi: 10.3389/fonc.2020.00674. eCollection 2020. Front Oncol. 2020. PMID: 32477940 Free PMC article.

2

The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance.

Shi Z, Parmar S, Peng XX, Shen T, Robey RW, Bates SE, Fu LW, Shao Y, Chen YM, Zang F, Chen ZS. Shi Z, et al. Among authors: chen ym, chen zs. Oncol Rep. 2009 Feb;21(2):483-9. Oncol Rep. 2009. PMID: 19148526 Free PMC article.

3

OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance.

Kuang YH, Patel JP, Sodani K, Wu CP, Liao LQ, Patel A, Tiwari AK, Dai CL, Chen X, Fu LW, Ambudkar SV, Korlipara VL, Chen ZS. Kuang YH, et al. Among authors: chen zs, chen x. Biochem Pharmacol. 2012 Sep 15;84(6):766-74. doi: 10.1016/j.bcp.2012.06.019. Epub 2012 Jun 28. Biochem Pharmacol. 2012. PMID: 22750060 Free PMC article.

4

Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10).

Deng W, Dai CL, Chen JJ, Kathawala RJ, Sun YL, Chen HF, Fu LW, Chen ZS. Deng W, et al. Among authors: chen jj, chen hf, chen zs. Oncol Rep. 2013 Jun;29(6):2479-85. doi: 10.3892/or.2013.2362. Epub 2013 Mar 22. Oncol Rep. 2013. PMID: 23525656 Free PMC article.

5

β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter.

Guo HQ, Zhang GN, Wang YJ, Zhang YK, Sodani K, Talele TT, Ashby CR Jr, Chen ZS. Guo HQ, et al. Among authors: chen zs. Oncol Rep. 2014 Feb;31(2):858-66. doi: 10.3892/or.2013.2870. Epub 2013 Nov 27. Oncol Rep. 2014. PMID: 24284783

6

Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.

Kathawala RJ, Chen JJ, Zhang YK, Wang YJ, Patel A, Wang DS, Talele TT, Ashby CR Jr, Chen ZS. Kathawala RJ, et al. Among authors: chen jj, chen zs. Int J Oncol. 2014 May;44(5):1634-42. doi: 10.3892/ijo.2014.2341. Epub 2014 Mar 13. Int J Oncol. 2014. PMID: 24626598 Free PMC article.

7

Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells.

Liu DL, Li YJ, Yang DH, Wang CR, Xu J, Yao N, Zhang XQ, Chen ZS, Ye WC, Zhang DM. Liu DL, et al. Among authors: chen zs. Int J Oncol. 2015 May;46(5):2029-38. doi: 10.3892/ijo.2015.2925. Epub 2015 Mar 12. Int J Oncol. 2015. PMID: 25779097

8

Selective reversal of BCRP-mediated MDR by VEGFR-2 inhibitor ZM323881.

Zhang YK, Zhang XY, Zhang GN, Wang YJ, Xu H, Zhang D, Shukla S, Liu L, Yang DH, Ambudkar SV, Chen ZS. Zhang YK, et al. Among authors: chen zs. Biochem Pharmacol. 2017 May 15;132:29-37. doi: 10.1016/j.bcp.2017.02.019. Epub 2017 Feb 27. Biochem Pharmacol. 2017. PMID: 28242251 Free PMC article.

9

Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistance.

Huang BY, Zeng Y, Li YJ, Huang XJ, Hu N, Yao N, Chen MF, Yang ZG, Chen ZS, Zhang DM, Zeng CQ. Huang BY, et al. Among authors: chen mf, chen zs. Int J Oncol. 2017 Jul;51(1):257-268. doi: 10.3892/ijo.2017.4005. Epub 2017 May 17. Int J Oncol. 2017. PMID: 28534954 Free PMC article.

10

Establishment and characterization of arsenic trioxide resistant KB/ATO cells.

Zhang YK, Dai C, Yuan CG, Wu HC, Xiao Z, Lei ZN, Yang DH, Le XC, Fu L, Chen ZS. Zhang YK, et al. Among authors: chen zs. Acta Pharm Sin B. 2017 Sep;7(5):564-570. doi: 10.1016/j.apsb.2017.04.001. Epub 2017 Apr 28. Acta Pharm Sin B. 2017. PMID: 28924550 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

876 results

Search Page

Filters